Menu
Back to Journals » Drug Design, Development and Therapy » Volume 14
Original Research
The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,830 | Dovepress* | 6,195+ | 1,004 | 7,199 | |
| PubMed Central* | 635 | 354 | 989 | ||
| Totals | 6,830 | 1,358 | 8,188 | ||
| *Since 31 July 2020 | |||||
View citations on PubMed Central and Google Scholar